for women, women's health, obstetrics, gynecology, infertility, pregnancy, hysterectomy, fibroids, and more

 

Print this page
OBGYN.net Advertisement
OBGYN.net - Correspondent: Dirk G. Kieback, MD

OBGYN.net Correspondent
Gynecologic Oncology

Dirk Günter Kieback, MD



BUSINESS ADDRESS Baylor College of Medicine
Department of Obstetrics and Gynecology
6550 Fannin, Room 740A
Houston, Texas 77030
BUSINESS PHONE (713) 798-8622
BUSINESS FAX (713) 798-5333

EDUCATION AND TRAINING

YEAR 

INSTITUTION

DEGREE

FIELD OF STUDY


UNDERGRADUATE		      
1966-1974 Gymnasium (High School and College) "Domschule" Schleswig, Germany    


GRADUATE		      
1980 Christian Albrechts-Universität Kiel, Germany M.D.  
1981 Christian Albrechts-Universität Kiel, Germany Dr. med. Clinical Pharmacology
1982-86 Eberhard-Karls-Universität Tuebingen, Germany Residency Obstetrics & Gynecology
1986-87 Westfälische Wilhelms-Universität, Münster, Germany   Residency Obstetrics & Gynecology
1988-90 Baylor College of Medicine Fellowship Cell Biology
1990-92 UT/MD Anderson Cancer Center Fellowship Gynecologic Oncology

APPOINTMENTS AND POSITIONS

NON-ACADEMIC POSITIONS

DATE

INSTITUTION

RANK
12/01/80 - 02/28/92 German Navy Staff Doctor (Hyperbaric Medicine, Emergency Medicine

ACADEMIC POSITIONS

DATE

INSTITUTION

RANK
91/13/93 - 02/17/93 Wayne State University, Department of Obstetrics and Gynecology, Detroit, Michigan Guest Professor
01/17/1993 UT/MD Anderson Cancer Center
Department of Gynecology,
Houston, Texas		 Visiting Professor
04/29/94 - 05/15/94 Tongi University,
Department of Obstetrics and Gynecology,
Wuhan, People’s Republic of China		 Visiting Professor
07/01/92 - 08/31/94 University of Ulm
Ulm, Germany		 Associate Professor
09/01/94 - Present University of Ulm
Ulm, Germany		 Adjunct Professor
09/01/94 - 6/30/95 Baylor College of Medicine
Department of Obstetrics & Gynecology
and Department of Cell Biology		 Research Associate Professor
07/01/95 - Present Baylor College of Medicine
Department of Obstetrics & Gynecology
and Department of Cell Biology		 Associate Professor
2/1/97 - Present U. T. M.D. Anderson Cancer Center
Department of Gynecologic Oncology		 Adjunct Associate Professor

HONORS AND AWARDS

04/01-30/89 Felix Rutledge Fellow in Gynecologic Oncology, UT/MD Anderson Cancer Center
1991 Certificate of Merit, UT/MD Anderson Cancer Center’s Annual Clinical Training Research Project Competition
05/14/94 Honorary Member and Scientific and Clinical Consultant, Chinese Medical Association, Wuhan Branch
4/04/95 First Prize Award in the category of Clinical Research for the 4th Annual Oncology Research Seminar. The Methodist Hospital Cancer Program, Houston, Texas

HOSPITAL APPOINTMENTS

October, 1994 Harris County Hospital District Active Staff
October, 1994 The Methodist Hospital Active Staff
3/9/95 St. Luke’s Episcopal Hospital Active Staff

NATIONAL AND INTERNATIONAL SCIENTIFIC PARTICIPATION

04/21-24/93 Session Chairman, Minorities, the Medically Underserved and Cancer; Cultural Diversity, Poverty, and Health Care Reform. Houston, Texas
1993 - Present Medical and Scientific Advisor to the Chinese Medical Association, Wuhan Branch, Peoples Republic of China
01/01/95 Organizing Committee. Fifth International Conference of Anticancer Research; October 17-22, 1995, Corfu, Greece
10/20/95 Session Chair: Ovarian Cancer. Fifth International Conference of Anticancer Research; October 17-22, 1995, Corfu, Greece
10/20/95 Session Chair: Biotherapy, Gene Therapy, Cancer Vaccines. Fifth International Conference of Anticancer Research; October 17-22, 1995, Corfu, Greece
2/5/96 Editorial Board of ANTICANCER RESEARCH
10/96 Editorial Board of Oncolog, U.T. M.D. Anderson Cancer Center
12/96 Editorial Board Current Drugs, Ltd, Middlesex House, UK

COMMITTEES

Cancer Committee, Harris County Hospital District Medical Staff
Clinical Investigators Subcommittee, The Methodist Hospital
Cancer Committee, The Methodist Hospital
Cancer Committee, St. Luke’s Episcopal Hosital
Operating Room Product Standardization and Review Subcommittee, The Methodist Hospital
Referring Physicians Advisory Panel, U.T. M.D.Anerson Cancer Center
The Breast Care Center Development Committee, The Methodist Hospital

CERTIFICATION AND LICENSURE

11/24/80 Unrestricted License to Practice Medicine in Germany
06/23/86 & 07/20/88 Basic Sciences, Clinical Science, and English Component of the Foreign Medical Graduates Examination in the Medical Sciences (FMGEMS)
04/25/87 Certified by the German Medical Board in Obstetrics and Gynecology
02/21/89 (ECFMG) Certified by The Educational Commission for Foreign Medical Graduates
June, 1993 (FLEX) Federal Licensing Examination given by The Pennsylvania State Board of Medicine

MEMBERSHIP IN PROFESSIONAL AND SCIENTIFIC SOCIETIES

American Association for the Advancement of Science (AAAS) 
American Association for Cancer Research (AACR) 
American Society of Clinical Oncology (ASCO) 
Association of Professors of Gynecology and Obstetrics (APGO) 
International Gynecological Cancer Society (IGCS) 
New York Academy of Science
M.D. Anderson Associates
Society For Gynecologic Investigation (SGI) 
The Endocrine Society 
The Felix Rutledge Society 
Arbeitsgemeinschaft für Gynäkologische Onkologie der (AGO) Deutschen Gesellschaft für Gynäkologie und Geburtshilfe und der Deutschen Krebsgesellschaft (Gynecologic Oncology Group of the German Society for Gynecology and Obstetrics and The German Cancer Society) 
Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (German Society for Gynecology and Obstetrics) 
Deutsche Gesellschaft für Senologie (German Society for the Study of Breast Disease) 
Deutsche Gesellschaft für Ultraschall in der Medizin (DEGUM German Society for Ultrasound in Medicine) 
Deutsche Krebsgesellschaft (German Cancer Society) 
Deutsch-Chinesische Gesellschaft Für Medizin E.V. 
 

CURRENT GRANTS

 GRANT  AGENCY  AMOUNT PERIOD PRINCIPAL INVESTIGATOR
Photodynamic Therapy of Ovarian Cancer German Cancer Society, Mildred Scheel Foundation  150,000 1994-1996 D.G. Kieback, M.D.,
Genetic Screening for Non-Familial Breast and Ovarian Cancer Risk Using Genosensor Technology Texas Higher Education Coordinating Board 112,632 1996-1997 D.G. Kieback, M.D.

Continued:

 GRANT  AGENCY  AMOUNT  PERIOD PRINCIPAL INVESTIGATOR
A Group of Mutations in the Human Progesterone Gene as a Risk Indicator for Non-Familial Ovarian Cancer The Women’s Fund 13,980 1/1/96-12/31/96 D.G. Kieback, M.D.
Gene Therapy of Ovarian Cancer   40,873 97-98 D.G. Kieback, M.D.
A Randomized, Double-Blind Study of Oral Ondansetron, 8mg BID, 24mg qd and 32mg qd in the Preven of Nausea and Vomiting Associated w/CisplatinChemotherapy   $18,000 97-98 D.G. Kieback, M.D.

VIDEOS

  1. Kieback, D.G., V.J. Möbus, R. Kreienberg: Der Einsatz des Cavitational Ultrasonic Surgical Aspirator (CUSA) in der tumorreduktiven Chirurgie bei Ovarialkarzinom. (translated title:The use of The Cavitational Ultrasonic Surgical Aspirator (CUSA) in tumor reductive surgery for ovarian cancer). 50. Wissenschaftliche Tagung der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, München, Germany, August 23-26, 1994.

  2. Kieback, D.G., Levy, T., Tumor Reductive Surgery for Ovarian Cancer. Video Journal of Ob/Gyn (VJOG) 3/27, 1997 release.

CASE REPORTS

  1. Kieback, D.G. C.C. Kieback: Advanced Breast Cancer after Subcutaneous Mastectomy and Immediate Prosthetic Reconstruction for Benign Breast Disease A Rare Observation and a Diagnostic Problem. Breast Cancer Research and Treatment 7/2 (1986) 119-120

  2. Möbus, V., I. Runnebaum, D.G. Kieback, R. Kreienberg: Vaginaler Fremdkörper (Zange) als Zufallsbefund anläßlich der Primäroperation eines Mammakarzinoms. (Translated title: Vaginal foreign body (wrench) as an accidential finding at primary surgery for breast cancer) Geburthilfe und Frauenheilkunde 55:4 233-234 (1995)

  3. Möbus, VJ, Runnebaum, I.B., Kieback, D.G., Kreienberg, R.: Der besondere fall: vaginaler fremdkörper (Zange) als zufallsbefund analäb lich der primäroperation eines mammakarzinomes. (Translated title: The special case: vaginal foreign body (forceps) as a chance finding during a primary operation of breast carcinoma). Geburtshilfe und Frauenheilkunde 55:4 233-234 (1995)

EXHIBITS

  1. Briel, R.C., D.G. Kieback, R.G.A. Schmucker, A.I. Schneider, T.H. Lippert: Influence of Low-Dose Heparin on the Platelet Sensitivity to Prostacyclin. Ixth International Congress on Thrombosis and Haemostasis, Stockholm, Sweden, Sverige, July 4-8, 1983

  2. Kieback, D.G., C.C. Honkomp, K.H. Pfeiffer, C. Pläcking: Primärdiagnose des Mammakarzinoms durch Ultraschall - Ergänzung der Routinediagnostik. (Translation: Primary diagnosis of breast cancer by ultrasound-Complimanting routine diagnostic procedures.) 5. Wissenschaftliche Tagung der Deutschen Gesellschaft für Senologie, Hamburg, Germany, June 7-9,1985

  3. Honkomp, C.C., D.G. Kieback, C. Pläcking, K.H. Pfeiffer: Plurizentrisches Mammakarzinom nach subkutaner Mastektomie und Einlage einer Silikonprothese - eine Kasuistik. (Translation: Pluricentric breast cancer after subcutaneous mastectomy and silicone breast implant - a case report) 5. Wissenschaftliche Tagung der Deutschen Gesellschaft für Senologie, Hamburg, June 7-9, 1985

  4. Briel, R.C., G. Lenz, U. Bissinger, D.G. Kieback, R. Ostertag, B. Saur: Coagulation Studies with a Stroma-Free Crosslinked Pyridoxylated Hemoglobin Solution in Mini-Pigs with Induced Hemorrhagic Shock. Xth International Congress on Thrombosis and Hemostasis, San Diego, California, July 14-19, 1985

  5. Kieback, D.G., C.C. Kieback, C. Köppe: Der Stellenwert der Mammasonographie in der Diagnostik des Mammakarzinoms.( Translation: The importance of breast sonography in the diagnosis of breast cancer), Bremer Krebskongreß 1989, Rathaus Bremen, Bremen, October 5-7, 1989

  6. Kieback, D.G., M. Grompe, M.R. Hughes, B.W. O'Malley: Rapid Detection of DNA Point Mutations in Genes Encoding Hormone Receptors. 37th Annual Scientific Meeting of The Society for Gynecologic Investigation, St. Louis, Missouri, March 21-24, 1990

  7. Roemer, V.M., D.G. Kieback: Apgar Scores and Neonatal Acid-Base Status - The Need for an Individualized Approach. 37th Annual Scientific Meeting of The Society for Gynecologic Investigation, St. Louis, Missouri, March 21-24, 1990

  8. Roemer, V.M., D.G. Kieback: The Impact of Maternal Cigarette Smoking on Fetal Carboxyhemoglobin Levels (HbCO) and Outcome of Pregnancy. 38th Annual Scientific Meeting of The Society for Gynecologic Investigation, San Antonio, Texas, March 20-23,1990

  9. Kieback, D.G., S.K. McCamant, E.N. Atkinson, R.A. Hajek, C.L. Edwards, H.S. Gallager, M.F. Press, L.A. Jones: The Impact of the Histologic Composition of Tumor Specimen on the Prognostic Significance of Estrogen Receptor Assays in Human Ovarian Cancer. 38th Annual Scientific Meeting of The Society for Gynecologic 	Investigation, San Antonio, Texas, March 20-23,1990

  10. Kieback, D.G., S.K. McCamant, E.N. Atkinson, R.A. Hajek, C.L. Edwards, H.S. Gallager, M.F. Press, L.A. Jones: Impact of Histologic Composition of Specimen on Prognostic Significance of Estrogen Receptor Assays in Human Ovarian Cancer. 82nd Annual Meeting of the American Association for Cancer Research, Houston, Texas, May 15-18, 1991

  11. Kieback, D.G., S.K. McCamant, M.-J. Tsai, C.L. Edwards, B.W. O'Malley, L.A. Jones: Differential Expression of COUP Transcription Factor in Ovarian Cell Lines. 44th Annual Symposium on Fundamental Cancer Research, Houston, Texas, October 29 - November 1, 1991

  12. Kieback, D.G., S.K. McCamant, E.N. Atkinson, R.A. Hajek, C.L. Edwards, H.S. Gallager, M.F. Press, L.A. Jones: Composition Adjusted Receptor Level (CARL) for the Estrogen Receptor: A Linear Predictor of Survival in Serous Ovarian Carcinoma. AACR Special Conference on Molecular Oncology as a Basis for New Strategies in Cancer Therapy, Honolulu, Hawaii, February 10-14,1992

  13. Kieback, D.G., M.F. Press, S.K. McCamant, E.N. Atkinson, C.L. Edwards, H.S. Gallager, L.A. Jones: The Prediction of Survival in Serous Ovarian Cancer by the Composition Adjusted Receptor Level (CARL) for Estrogen and Her-2/neu Oncogene Expression. 23rd Annual Meeting of The Society of Gynecologic Oncologists, San Antonio, Texas, March 15-18, 1992

  14. Kieback, D.G., S.K. McCamant, M.-Y. Tsai, M.A. Thompson, M.F. Press, C.L. Edwards, B.W. O'Malley, L.A. Jones: COUP - A Steroid Receptor Protein with a Specific Pattern of Differential Expression in Human Ovarian Cancer Cell Lines. 39th Annual Meeting of the Society for Gynecologic Investigation, San Antonio, Texas, March 18-21, 1992

  15. Kieback, D.G., König, R., Headon, D.R., Gause, H., Runnebaum, I.B., Möbus, V.J., Körner, Kreiienberg, R: A genetic mutation in the human progesterone receptor gene (HPR) is associated with ovarian cancer. 26th annual meeting of the Society of Gynecologic Oncologists, San Francisco, February 18-22, 1995

  16. Levy,T.; Fiedrich U.; Möbus,V.J., Press, M.F., Rosenthal, H.E.; Tong X.-W.; Runnebaum, I.B.; Gause , H. M.; Tsai, M.-J.; Kieback, D.G. Chicken ovalbumin upstream promoter - transcription factor (COUP-TF-like) expression in human endometrial cancer cell lines. 86th Annual Meeting of the American Association for Cancer Research, March 18-22, 1995, Toronto, Ontario, Canada.

  17. Kieback D.G, Fiedrich U., Press M.F., Rosenthal H.E., Tong X.-W. , Runnebaum I.B. , Möbus V.J., Gause H.M., Tsai M.-J.Chicken ovalbumin upstream promoter - transcription factor (COUP-TF-like) expression in human ovarian cancers. 86th Annual Meeting of the American Association for Cancer Research, March 18-22, 1995, Toronto, Ontario, Canada.

  18. Tong X.-W. , König R. , Headon D. R., Gause H.M., Runnebaum I.B., Möbus V.J., Körner K., Kreienberg R., Kieback D.G. RFLP in the human progesterone receptor gene (hpr) is associated with ovarian cancer. 86th Annual Meeting of the American Association for Cancer Research, March 18-22, 1995, Toronto, Ontario, Canada.

  19. Runnebaum I.B., Tong X.-W., Wang, S., Möbus V.J., Kreienberg R., Kieback D.G.: p53 inactivation and WAF1 expression of tumorigenic and nontumorigenic newly established ovarian cancer cell lines. 86th Annual Meeting of the American Association for Cancer. Toronto, Ontario, Canada, March 18-22, 1995

  20. Tong X.W., Konig, R., Headon, D. R., Gause, H. M. Runnebaum, I. B., Möbus, V.J., Korner, K., Kreienberg, R., Kieback D.G.: A Taq 1 RFLP in the human progesterone receptor gene(hpr) is associated with ovarian cancer. 4th Annual Cancer Research Seminar, The Methodist Hospital, Houston, Texas,. April 2, 1995

  21. Kieback D.G., Fiedrich, U., Press, M. F., Rosenthal, H. E., Tong X.W., Runnebaum, I. B., Möbus, V.J., Gause, H., Tsai M.-J.: Chicken ovalbumin upstream promoter-transcription factor (COUP-TF-like) expression in human ovarian cancers. 4th Annual Cancer Research Seminar, The Methodist Hospital, Houston, Texas, April 2, 1995

  22. Levy, T., Fiedrich, U., Möbus, V.J., Rosenthal, H. E., Tong X.W., Runnebaum, I. B., Gause, H., Tsai M.-J., Kieback D.G.: Chicken ovalbumin upstream promoter-transcription factor (COUP-TF-like) expression in human endometerial cancer cell lines. 4th Annual Cancer Research Seminar, The Methodist Hospital, Houston, Texas, April 2, 1995

  23. *Kieback D.G., Tong X.-W., Block,A., Kaufman,R.H., Woo,S.L.C.: In vivo gene therapy of ovarian cancer -adenovirus mediated transfection of a suicide gene. Fifth International Conference of Anticancer Research, Korfu, Greece. Anticancer Res 15: 1775 (1995)

  24. Kieback D.G., Tong X.-W., Block, A., Kaufman, R.H., Woo, S.L.C.: In vivo gene therapy of ovarian cancer with adenovirus mediated transfection of a HSV-TK-Gene and cell kill by exposure to ganciclovir. 27th Annual Meeting of the Society of Gynecologic Oncologists (SGO), New Orleans, Louisiana, February 10-14, 1996.

  25. Kieback D.G, Tong, X.,-W., Block, A., Kaufman, R.H., Woo, S.L.C. In vivo gene therapy of ovarian cancer with adenovirus mediated transfection of a HSV-TK-gene and cell kill by exposure to ganciclovir. 27th Annual Meeting of the Society of Gynecologic Oncologists (SGO), New Orleans, Louisiana, February 10-14, 1996.

  26. Tong, X.W., Block, A., Kaufman, R.H., Woo, S.L.C., Kieback D.G.: Adenovirus mediated gene therapy of ovarian cancer by transfection of a suicide gene. Forty third Annual Scientific meeting of the Society For Gynecologic Investigation, Philadelphia, Pennsylvania, March 20-23, 1996.

  27. Kieback D.G., Tong, X.W., Körner, W., Atkinson, E.N., Hettinger, B., König, R. Runnebaum, I.B: The TAQ I RFLP in the human progesterone gene (HPR) specifically associated with sporadic epithelial ovarian cancer and with breast cancer cosegregates with two exon point mutations giving rise to a mutated HPR protein. Forty-third Annual Scientific meeting of the Society For Gynecologic Investigation, Philadelphia, Pennsylvania, March 20-23, 1996.

  28. Kieback D.G., Tong, X.W., König, R., Körner, W., Blankenburg, K., Agoulnik, I., Runnebaum, I.B., Atkinson, E.N.: A complex of mutations in the human progesterone receptor gene is associated with increased risk of non-familial breast and ovarian cancer but not of uterine cancer. 87th Annual meeting of the American Association for Cancer Research, Washington, D.C., April 20-24, 1996.

  29. Levy, T., Gause, H.M., Tong, X-W., Kieback D.G.: Telomere length in human peripneral white blood cells is constant inter-individually and remains stable with aging. 87th Annual meeting of the American Association for Cancer Research, Washington, D.C., April 20-24, 1996.

  30. Agoulnik, I., Weigel, N., Tong, X.-W., Blankenburg, K., Kieback D.G.: Genetic mutations in the human progesterone receptor gene associated with increased cancer risk lead to a structurally and functionally altered receptor protein. 87th Annual meeting of the American Association for Cancer Research, Washington, D.C., April 20-24, 1996.

  31. Tong, X.-W., Chen, S.-H., Block, A., Content, C.F., Agoulnik, I., Blankenburg, K., Kaufman, R.H., Woo, S.L.C., Kieback D.G.: Adenovirus-mediated gene therapy for ovarian cancer in vitro and in vivo. 87th Annual meeting of the American Association for Cancer Research, Washington, D.C., April 20-24. 1996.

  32. Kieback D.G., Tong, X.W., König, R., Körner, W., Blankenburg, K., Agoulnik, I., Runnebaum, I.B., Atkinson, E.N.: A complex of mutations in the human progesterone receptor gene is associated with increased risk of non-familial breast and ovarian cancer but not of uterine cancer. 5th Annual Cancer Research Seminar, The Methodist Hospital, Houston, Texas, April 2, 1996.

  33. Levy, T., Gause, H.M., Tong, X-W., Kieback D.G.: Telomere length in human peripheral white blood cells is constant inter-individually and remains stable with aging. 5th Annual Cancer Research Seminar, The Methodist Hospital, Houston, Texas, April 2, 1996..

  34. Agoulnik, I., Weigel, N., Tong, X.-W., Blankenburg, K., Kieback D.G.: Genetic mutations in the human progesterone receptor gene associated with increased cancer risk lead to a structurally and functionally altered receptor protein. 5th Annual Cancer Research Seminar, The Methodist Hospital, Houston, Texas, April 2, 1996.

  35. Tong, X.-W., Chen, S.-H., Block, A., Content, C.F., Agoulnik, I., Blankenburg, K., Kaufman, R.H., Woo, S.L.C., Kieback D.G.: Adenovirus-mediated gene therapy for ovarian cancer in vitro and in vivo. 5th Annual Cancer Research Seminar, The Methodist Hospital, Houston, Texas, April 2, 1996.

  36. X.-W. Tong, Körner, W., Runnebaum, I.B., D.G.Kieback: Ein genetischer Defekt im Progesteronrezeptoren ist spezifisch Ovarialkarzinomrisiko 51th Annual Meeting of Obstetrics and Gynecology of Germany, Dresden, Germany, October, 1-5, 1996

  37. Kieback D.G., X.-W. Tong, R. Konig, W. Körner, B. Hettinger, K. Blankenburg, I. Agoulnik, I.B. Runnebaum, E.N.Atkinson: A mutated allele of the human progesterone receptor gene is associated with increased risk of non-familial breast and ovarian cancer but not of uterine cancer. 49th Annual Symposium on Fundamental Cancer Research, Houston., Texas, Oct.22-25,1996

  38. X.-W. Tong, S.-H Chen, A. Block, C.F. Content, I.Agoulnik, K.Blankenburg, R.H. Kaufman, S.L.C. Woo, Kieback D.G.: Adenovirus-mediated thymidine kinase gene therapy of human epithelial ovarian cancer in vitro and vivo. 49th Annual Symposium on Fundamental Cancer Research, Houston, Texas, Oct.22-25,1996

  39. Agoulnik I, Weigel, N., Tong, X.-W., Bingman, W.E., Blankenburg, K., Kieback D.G.: Genetic mutations in the human progesterone receptor gene associated with increased cancer risk lead to a structurally and functionally altered receptor protein. 49th Annual Symposium on Fundamental Cancer Research, Houston, Texas, Oct.22-25,1996

  40. Kieback D.G., X.-W. Tong, Z.-S. Guo, A. Block, C.F. Contant, I. Agoulnik, K. Blankenburg, R.H. Kaufman, S.-H Chen, S.L.C.Woo: Comparision of cell killing efficacy of ADV/CMVTK and ADV/RSV-TK mediated gene therapy in ovarian cancer. Forty-third Annual Scientific meeting of the Society For Gynecologic Oncology, San Diego, California, Feb 20-23, 1997.

ORAL PRESENTATIONS AT SCIENTIFIC MEETINGS

  1. Kieback, D.G., R.C. Briel, T.H. Lippert, B. Dieter, C. Brodmann, I. Joos: Veränderungen der Prostazyklin-Sensitivität der Thrombozyten während der Gravidität und im Wochenbett.(Translated title: Platelet sensitivity to prostacyclin in normal pregnancy and puerperium)First International Austrian Prostaglandin Meeting, Bad Ischl, Austria, September 22-25,1982

  2. Kieback, D.G., R.C. Briel, T.H. Lippert, B. Dieter, C. Brodmann, I. Joos: Platelet Sensitivity to Prostacyclin in Normal and Pathological Pregnancy.Seventh International Congress on Thrombosis, Valencia, Spain, October 13-16,1982

  3. Kieback, D.G., R.C. Briel, R.G.A. Schmucker, A.I. Schneider: Neue gerinnungsphysiologische Aspekte der Thrombosegefährdung bei Radiumbestrahlung gynäkologischer Karzinome. (Translated title: New aspects of hemostaseology in the radium treatment of uterine cancer)100. Tagung der Oberrheinischen Gesellschaft für Geburtshilfe und Gynäkologie, Tübingen, October 1-2,1983(Obstetrical and Gynecological Society of the Upper Rhine, (Germany, France, Austria, Switzerland)

  4. Kieback, D.G., R.C. Briel, A.I. Schneider, R.G.A. Schmucker: The Influence of Local Therapeutic Irradiation on Platelet Aggregation and Platelet Sensitivity to Prostacyclin in Patients with Uterine Cancer.XX. Congress of the International Society of Hematology, Buenos Aires, Argentina, September 1-7,1984

  5. Kieback, D.G., A.H. Entenmann, H. Seeger, T.H. Lippert, W. Voelter: Blutspiegel von Relaxin im fetalen Kreislauf.(Translated title: Serum levels of relaxin in the fetal circulation) 45. Tagung der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, Frankfurt a. M. September 18-22, 1984 (German Society for Obstetrics and Gynecology)

  6. Kieback, D.G., T.H. Lippert: Clinical Evaluation of Endocervical Prostaglandin E2-Triacetin-Gel for Cervical Softening in Pregnant Women at Term. Kyoto Conference on Prostaglandins, Kyoto, Japan, November 23-28, 1984

  7. Pfeiffer, K.H., C.C. Kieback, D.G. Kieback, E. Leydig: Prenatal Diagnosis of Severe Fetal Malformations by Ultrasonography - Key to Postnatal Therapy. The 2nd International Symposium" The Fetus as a Patient - Diagnosis and Therapy", Jerusalem, Israel, May 26-31, 1985

  8. Roemer, V.M., D.G. Kieback, K. Bühler: Some Aspects of Fetal Surveillance During Labor in the Federal Republic of Germany.The 2nd International Symposium" The Fetus as a Patient - Diagnosis and Therapy", Jerusalem, Israel, May 26-31, 1985

  9. Kieback, D.G., R.C. Briel, A.I. Schneider, R.G.A. Schmucker: The Influence of Local Therapeutic Irradiation on Platelet Aggregation and Platelet Sensitivity to Prostacyclin in Patients with Uterine Cancer. XIth World Congress of Gynecology and Obstetrics, West Berlin, September 15-20, 1985

  10. Roemer, V.M., D.G. Kieback: The Influence of Premature Rupture of the Membranes (PROM) on the Course of Labor. International Symposium "Problems of the Pelvic Passageway", Bremen, September 21-23, 1985

  11. Roemer, V.M., B. Gern, D.G. Kieback: Instrumental Vaginal Delivery Today: Forceps Delivery Versus Vacuum Extraction. International Symposium "Problems of the Pelvic Passageway", Bremen, September 21-23, 1985

  12. Kieback, D.G., T.H. Lippert: Zervixreifung am Termin mit intrazervikal appliziertem Prostaglandin E2 Triacetin Gel. (Translated title: Cervical ripening at term with intracervival prostaglandin E2-triacetin gel)12. Deutscher Kongress für Perinatale Medizin, West Berlin, December 3-6, 1985 (German Society for Perinatal Medicine)

  13. Kieback, D.G.: Indikationen für die Blutdruckintensivüberwachung in Gynäkologie und Geburtshilfe. (Translated title: Indications for intensive blood pressure monitoring in gynecology and obstetrics) Critikon-Symposium, Bad Eib, Österreich, December 14, 1985

  14. Kieback, D.G., C.C. Kieback, K.H. Pfeiffer: Das nur sonographisch darstellbare Mammakarzinom - Kriterien der Indikationsstellung zur Mammasonographie. (Translated title: The breast cancer detectable exclusively by ultrasound - criteria of the indications for an ultrasound examination of the breast) 46. Tagung der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, Düsseldorf, September 22-26,1986 (German Society for Obstetrics and Gynecology)

  15. Roemer, V.M., D.G. Kieback, K.H. Pfeiffer: Beobachtungen zum Einfluß der Gestationsdauer und der fetalen Hypotrophie auf den Säure-Basen-Haushalt des Neugeborenen.(Translated title: The influence of the gestational age and fetal growth retardation on the acid-base status of the newborn)46. Tagung der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, Düsseldorf, September 22-26, 1986(German Society for Obstetrics and Gynecology)

  16. Kieback, D.G., C.C. Kieback, K.H. Pfeiffer: Die sonographische Früherkennung des Mammakarzinoms. (Translated title: Early diagnosis of breast cancer by ultrasound)10. Gemeinsame Tagung der Deutschsprachigen Gesellschaften für Ultraschall in der Medizin, Bonn, October 1-5, 1986 (German Speaking Societies for Ultrasound in Medicine, involves Germany, Austria, Switzerland)

  17. Kieback, D.G., C.C. Kieback, K.H. Pfeiffer: Häufigkeit und Ursache mammasonographischer Fehldiagnosen. (Translated title: Frequency of and reasons for sonographic misdiagnosis in ultrasonography of the breast)10. Gemeinsame Tagung der Deutschsprachigen Gesellschaften für Ultraschall in der Medizin, Bonn, October 1-5,1986 (German Speaking Societies for Ultrasound in Medicine, involves Germany, Austria, Switzerland)

  18. Seitzer, D., F.K. Beller, W. Niedner, U. Winkler, D.G. Kieback, W. Holzgreve: Ergebnisse mit der eingeschränkten subkutanen Mastektomie mit Eigenaufbau - einem primär rekonstruktiven Operationsverfahren. (Translated title: Results of the modified subcutaneous mastectomy with autologous reconstruction) 98. Tagung der Nordwestdeutschen Gesellschaft für Gynäkologie und Geburtshilfe, Berlin, May 1-3, 1987 (North-West German Society of Obstetrics and Gynecology)

  19. Kieback, D.G., M. Reiser: Der Stellenwert der Mammasonographie in der apparativen Mammadiagnostik in Gegenüberstellung zur Mammographie. (Translated title: The place of the ultrasonographic examination among the diagnostic means for breast cancer in comparison to mammography)Symposium: Ultraschalldiagnostik in Gynäkologie und Geburtshilfe, Münster, April 26, 1987

  20. Kieback, D.G., C.C. Kieback: Sonographie der Mammae(Translated title: Ultrasound of the breast) Fortbildungsveranstaltung des Berufsverbandes der Frauenärzte Westfalen-Lippe, Dortmund, November 21,1987 (and on multiple other dates) (Series of Lectures for German Medical Association credit invited by the Chamber of Physicians of Westfalia)

  21. Kieback, D.G., F.K. Beller, C.D. Nitsch: Das Mikrokarzinom der Mamma - ein sinnvoller Begriff? (Translated title: "Minimal Breast cancer" - a reasonable term ?) 47. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, München, September 6-10,1988 (German Society for Obstetrics and Gynecology).

  22. Kieback, D.G., C.C. Kieback, C. Köppe, K.H. Pfeiffer: Die Leistungsfähigkeit der Mammasonographie bei der Frühdiagnose des Mammakarzinoms. (Translated title: The performance of breast sonography in the early diagnosis of breast cancer) Frühjahrstagung der Oberrheinischen Gesellschaft für Geburtshilfe und Gynäkologie, Baden-Baden, May 26-27, 1989 (Obstetrical and Gynecological Society of the Upper Rhine, involves Germany, France, Austria, Switzerland)

  23. Kieback, D.G., M.R. Hughes, B.W. O'Malley: Mutations in the DNA-Binding Domain of the Human Vitamin D Receptor Gene Cause Hypocalcemic Rickets. Symposium on New Aspects in Steroid Receptor Research, Baylor College Of Medicine, Houston, Texas, July 1, 1989

  24. Kieback, D.G., S.F. Fuqua, M.R. Hughes, W.L. McGuire, B.W. O'Malley: Mutationen im Östrogen und Progesteronrezeptor bei Mammakarzinom. (Translated title: Mutations in estrogen - and progesterone receptors in breast cancer) 48. Kongress der Deutschen Gesellschaft für Gynäkologie und 	Geburtshilfe, Hamburg, September 11-15,1990 (German Society for Obstetrics and Gynecology)

  25. Kieback, D.G., S.K. McCamant, E.N. Atkinson, C.L. Edwards, H.S. Gallager, M.F. Press, L.A. Jones: Estrogen receptor expression as a prognostic indicator in ovarian cancer. The Twenty Second Annual Felix Rutledge Society Meeting, Houston, Texas, May 22-25,1991

  26. Kieback, D.G., S.K. McCamant, M.F.Press, E.N. Atkinson, H.S. Gallager, C.L. Edwards, L.A. Jones: Improved Prediction of Survival in Advanced Serous Carcinoma of the Ovary by Composition Adjustment and Immunocytochemical Analysis of the Estrogen Receptor. Award ceremony presentation, University of Texas System M.D. Anderson Cancer Center, Houston, Texas, June 5, 1991

  27. Kieback, D.G., M.F. Press, S.K. McCamant, E.N. Atkinson, C.L. Edwards, H.S. Gallager, L.A. Jones: Composition Adjusted Receptor Level (CARL) for the Estrogen Receptor: A Linear Predictor of Survival in Serous Ovarian Carcinoma. The Annual Meeting of The Endocrine Society, Washington DC, June19-22, 1991

  28. Kieback, D.G.: Die Bedeutung der Molekularbiologischen Forschung für die gynäkologische Onkologie.(Translated title: The importance of molecular biology for gynecologic oncology) Fortbildungsvortrag, Kreiskrankenhaus Heppenheim, February 4, 1992

  29. Kieback, D.G., S.K. McCamant, C.L. Edwards, M.F. Press, M. Thompson, M.-Y. Tsai, B.W. O'Malley, L.A. Jones: COUP - An Orphan Steroid Receoptor on Its Way to Clinical Application. The Twenty Third Annual Felix Rutledge Society Meeting, Nashville, Tennessee, June 3-6, 1992

  30. Kieback, D.G., S.K. McCamant, E.N. Atkinson, L.A. Jones: Der Composition Adjusted Receptor Level (CARL) des Östrogenrezeptors ermöglicht eine individuelle Prognosestellung beim serösen Ovarialkarzinom.(Translated title: The Composition Adjusted Receptor Level (CARL) permits determination of the individual prognosis in serous ovarian cancer) 49. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, Berlin, September 9-12, 1992 (German Society for Obstetrics and Gynecology)

  31. Kieback, D.G.: Structure-Function Relationship of Genes and their Significance for Gynecologic Oncology.Grand Rounds in Gynecology and Obstetrics, Wayne State University, Detroit, Michigan, February 16, 1993

  32. Kieback, D.G. :Selected Aspects of Molecular Biology in Gynecologic Oncology. Grand Rounds in Gynecology and Obstetrics, Baylor College of Medicine, Houston, Texas, February 17, 1993

  33. Kieback, D.G.: Perspectives of Molecular Biology in Gynecologic Oncology. Grand Rounds, Department of Gynecology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, February 18, 1993

  34. Kieback D G, E.N. Atkinson, L.A. Jones, R. Kreienberg: Der Composition Adjusted Receptor Level (CARL) des Östrogenrezeptors ermöglicht eine individuelle Prognosestellung beim serösen Ovarialkarzinom. (Translated title: Determination of the individual prognosis in serous ovarian cancer)Tagung Deutschsprachiger Hochschullehrer in Gynäkologie und Geburtshilfe, Hannover, May 17, 1993 (Conference of German Speaking Academic Teachers in Gynecology and Obstetrics, involving Germany, Austria, Switzerland)

  35. Kieback, D.G., T.W. Burke: Modified Instruments for Mobilization of the Ureters and Parametrial Transsection during Radical Hysterectomy. The Twenty Fourth Annual Felix Rutledge Society Meeting, Laguna Beach, California, June 3, 1993

  36. Kieback, D.G.: Aktuelle Therape des Ovarialkarzinoms. (Translation: Current therapy of ovarian cancer) Onkologischer Arbeitskreis, Klinikum Ingolstadt, June, 1994

  37. Cervical Cytology And He New Bethesda Classification. Ob/Gyn Update for Primary Care Physicians, St. Luke’s Episcopal Hospital, Houston, Texas, December 3, 1994

  38. Oncogenes and T-Suppressive Gene. Grand Rounds, The Methodist Hospital, Houston, Texas, December 6, 1994

  39. Aspects of Steroid Receptor Research in Gynecologic Malignancies. Academic Conference, Section of Gynecologic Medical Oncology, UT/MD Anderson Cancer Center, Houston, Texas, January 13, 1995

  40. Treatment of Invasive Carcinoma of the Vulva. 12th Biennial Conference on Diseases of the Vulva and Vagina, Baylor College of Medicine, Houston, Texas, January 19-21, 1995

  41. Molecular Epidemiology, Role of Steroid Receptors and Other Transcription Factors in Gynecologic Malignancies. Division of Cancer Prevention Friday Seminar Series, UT/MD Anderson Cancer Center, Houston, Texas, February 3, 1995

  42. Ovarian Cancer and Infertility - Should we worry? Resolve of Houston, Houston, Texas, March 2, 1995

  43. D.G. Kieback, H.M. Gause, W. Körner, R. König, I.B. Runnebaum, V.J. Möbus, R. Kreienberg, X.-W. Tong, D.R. Headon, A Taq 1 RFLP in the Human Progesterone Receptor Gene is Associated with Sproadic Epithelial Ovarian Cancer and with Breast Cancer. 42nd Annual SGI Meeting, March 15-18, 1995, Chicago, Illinois.

  44. Kieback, D. G. Fiedrich, U., Press, M. F., Rosenthal, H. E., Tong X.W., Runnebaum, I B., Möbus, V.J., Gause, H., W Tsai M.-J.: Chicken ovalbumin upstream promoter-transcription factor (COUP-TF-like) expression in human ovarian cancers. American Association for Cancer Research 86th Annual Meeting, Metro Toronto Convention Center, Toronto, Ontario, Canada, March 18-22, 1995

  45. Novel Concepts in the Diagnosis and Treatment of Ovarian Cancer. Department of Medical Oncology, Alexander Humboldt University, Berlin, Germany, April 24, 1995.

  46. Treatment Concepts of Ovarian Cancer. Interdisciplinary Grand Rounds., University of Ulm, Germany, April 27, 1995.

  47. Visiting Professor, Student Teaching, University of Ulm, Germany, April 25-27, 1995

  48. Tong X.W, D.G. Kieback: Genetic alteration of hPR receptor gene in sporadic ovarian and breast cancer. Department of Cell Biology, Baylor College of Medicine, Houston , Texas, June 23, 1995.

  49. New Developments in the Diagnosis of Ovarian Cancer. Oncology Grand Rounds, Woman’s Hospital of Texas, August 18, 1995. Houston, Texas.

  50. Visiting Professor, Vienna Medical School, Vienna, Austria, January 15, 1996.

  51. Die Zukunft der Krebs Therapie (Translation: The Future of Gene Therapy). Seminarkongress des Frauemarztes, Berlin, Germany, February 28 - March 3, 1996.

  52. The TAQ I RFLP in the human progesterone gene (HPR) specifically associated with sporadic epithelial ovarian cancer and with breast cancer cosegregates with two exon point mutations giving rise to a mutated HPR protein. 43rd Annual SGI Scientific Meeting, March 20-24, 1996, Philadelphia Pennsylvania

  53. Tong X.W., A. Block, S.-H Chen, C.F. Contant, I.Agoulnik, K.Blankenburg, R.H. Kaufman, S.L.C. Woo, D.G. Kieback: Adenovirus-mediated gene therapy of ovarian cancer by of a suicide gene. SGI meeting plenary session), Philadelphia, Pennsylvania, March 21-25, 1996

  54. Cancer Program Moderator, 5th Annual Cancer Research Seminar, The Methodist Hospital, April 2, 1996, Houston, Texas.

  55. Ovarian Cancer Lecture to Physician Assistant and Nurse Midwifery Program. Baylor College of Medicine, April 4, 1996, Houston, Texas.

  56. Levy, T., Gause, H.M., Tong, X-W., Kieback, D.G.: Telomere length in human peripheral white blood cells is constant inter-individually and remains stable with aging. 87th Annual meeting of the American Association for Cancer Research, Washington, D.C., April 20-24, 1996.

  57. Agoulnik, I., Weigel, N., Tong, X.-W., Blankenburg, K., Kieback, D.G.: Genetic mutations in the human progesterone receptor gene associated with increased cancer risk lead to a structurally and functionally altered receptor protein. 87th Annual meeting of the American Association for Cancer Research, Washington, D.C., April 20-24, 1996.

  58. X.-W. Tong, A. Block, S.-H Chen, C.F.Contant, I. X Agoulnik, K.Blankenburg, R.H.Kaufmann, S.L.C.Woo; D.G.Kieback: Genetherapy in ovarian cancer. Annual Cancer Research Seminar, The Methodist Hospital, Houston, Texas, April 2, 1996

  59. D.G.Kieback., X.-W. Tong, A. Block, S.L.C.Woo,: In vivo Gentherapie des Ovarialkarzinomas durch adenovirale tranduktion mit einem Herpes simplex Thymidinkinase Gen Und Ganciclovir Exposition . 51th Annual Meeting of Obstetrics and Gynecology of Germany, Dresden, Germany, October, 1-5, 1996

  60. D.G.Kieback., X.-W. Tong(translator). Current treatment of ovarian cancer. Special Seminar, Beijing Medical University, Beijing, P.R.China, Nov. 5, 1996

  61. D.G.Kieback., X.-W. Tong(translator): Current treatment of invasive vulva cancer. Special Seminar, Medical Association of Obstetrics and Gynecology of Yantze River(six provinces and cities), Chongqing, P.R. China, Nov. 8, 1996

  62. D.G.Kieback., X.-W. Tong(translator): Current treatment of ovarian cancer. Special Seminar, Medical Association of Obstetrics and Gynecology of Yantze River(six provinz and cities), Chongqing, P.R. China, Nov. 8, 1996

  63. D.G.Kieback., X.-W. Tong(translator): Current treatment of invasive vulva cancer. Special Seminar, Wuhan Medical Association, Wuhan ,P.R. China, Nov. 12, 1996

  64. D.G.Kieback., X.-W. Tong(translator): Current treatment of ovarian cancer. Special Seminar, Wuhan Medical Association, Wuhan ,P.R. China, Nov. 12, 1996

  65. X.-W. Tong, D.G.Kieback: Gene therapy of ovarian cancer. Special Seminar, Wuhan Medical Association, Wuhan ,P.R. China, Nov. 12, 1996

  66. Cancer Program Moderator, 5th Annual Cancer Research Seminar, The Methodist Hospital, April 2, 1996, Houston, Texas.

 

ARTICLES (* marks alphabetical listing of authors regardless of significance of individual contribution)

  1. Runnebaum, I.B., Kieback, D.G., Möbus, V.J., Tong, X-W, Kreienberg, R.: Subcellular localization of accumulated p53 in ovarian cancer cells. Gynecol. Oncol. 61: 266-271 (1996)

  2. Tong, X.-W., Block, A., Chen, S-H., Woo, S.L.C., Kieback, D.G. Adenovirus-Mediated Thymidine Kinase Gene Transduction of Human Epithelial Ovarian Cancer Cell Lines Followed by Exposure to Ganciclovir. Anticancer Research, 16:4, 1611-1618 (1996).

  3. Kieback, D.G., Burke, T.W.: The application of novel parametrial clamps and scissors to total abdominal hysterectomy. J. Gynecol. Tech., 2:1, 43-47 (1996)

  4. Tong, X.-W., Block, A., Chen, S.H., Contant, C.F., Agoulnik, I., Blankenburg, K., Kaufman, R.H., Woo, S.L.C., Kieback, D.G. In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration. Gynecol. Oncol. 61: 175-179, (1996)

  5. Kudelka, A.P., Verschraegen, D.F., Levy, T., Edwards, C.L., Fishman, A.,Freedman, R.S., Kaplan, A., Kieback, D.G., Mante, R., Steger, M., Kavanagh, J.J. Premilinary Report of the Activity of Docetaxel in Advnaced or Recurrent Squamous Cell Cancer of the Cervix. Anti Cancer Drugs 7:398-401, 1996.

  6. Runnebaum, I.B., Köhler, T., Stickeler, E., Rosenthal, H.E., Kieback, D.G., Kreienberg, R. p53 mutation is associated with high S phase fraction in primary fallopian tube adenocarcinoma. Brit. J. Cancer, 74:1157-1160 (1996)

  7. Kieback, D.G., Levy, T., Kohlberger, P., Fiedrich, U., Press, M.F., Rosenthal, H.E., Möbus, V.J., Runnebaum, I.B., Tong, X.-W., Gause, H.M., Tsai, M.-J. Chicken Ovalbumin Upstream Promoter - Transcription Factor (COUP-TF) Expression in Human Endometrial Cancer Cell Lines. Anti Cancer Res 16:6, 3371-3376, 1996
  8. Verschraegen, C.F., Levy, T., Kudelka, A.P., Llerena, E., Ende, K., Freedman, R.S., Edwards, C.L., Hord, M., Steger, M., Kaplan, A.L., Kieback, D.G., Fishman, A., Kavanagh, J.J. Phase II study of Irinotecan in Prior Chemotherapy Treated Squamous Cell Carcinoma of the Cervix. J. Clin Oncol. 15:2, 625-631 (1997)
  9. Tong, X. -W., Agoulnik, I.A., Blankenburg, K., Contant, C.F., Hasenburg, A., I.B. Runnebaum, e. Stickeler, A.L. Kaplan, S.L.C. Woo, Kieback, D.G. Human epithelial ovarian cancer xenotransplants into nude mice can be cured by adenovirus-mediated thymidine kinase gene therapy. Anticancer Research 17:2A, 811-813, 1997

  10. Möbus, V.J., Stein, R., Kieback, D.G., Runnebaum, I.G. Sass, G., Kreienberg, R.: Antitumor activity of new organometallic compounds in human ovarian cancer cell lines and comparison to platin derivatives. Anticancer Research, 17:2A, 815-821, 1997

  11. Hasenburg, A., Kieback, D.G. Gestationsbedingte Trophoblasterkrankungen-Eine Übersicht. Der Frauenzrzt, 38:1, 176-179, 1997

  12. Kohlberger, P., Kieback, D.G., Breitenecker, F., Loesch, A., Gitsch, G., Kainz, C., Breitenecker, G.: Epithelial and Stromal Estrogen and Progesterone Receptor Expression in Endometrial Cancer: True Color Computer-Assisted Image Analysis versus Subjective Scoring. Gynecol. Oncol., 64:404-410 (1997)
  13. Skinner, S.M., V. Lee, D.G. Kieback, L.A. Jones, A.L. Kaplan, B.S. Dunbar: Identification of a Meiotically Expressed Carbohydrate Antigen in Ovarian Carcinoma: I. Immunohistochemical Localization. . Anticancer Res, 17:2A, 901-906, 1997

  14. Skinner, S.M., V. Lee, D.G. Kieback, L.A. Jones, A.L. Kaplan, B.S. Dunbar: Identification of a Meiotically Expressed Carbohydrate Antigen in Ovarian Carcinoma: II, Association with Proteins in Tumors and Peritoneal Fluid. Anticancer Res, 17:2A, 907-911, 1997

  15. Stickeler, E., Runnebaum, I.B., Möbus, V.J., Kieback, D.G., Kreienberg, R.: Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines. Anticancer Res 17:4 1997 (In press).

  16. Kohlberger, P.D., Kieback, D.G., Bancher, D., Stickeler, E., Heinzl, H., Gitsch, G., Breitenecker, G., Kainz, C: Immunohistochemical Detection of CD44 splice variant expression in premalignant lesions of the cervix and benign cervical epithelium. Gynecologic Oncology, Accepted 3/5/97

ARTICLES SUBMITTED:

  1. Runnebaum, I.B. Wang, S., D.G. Kieback, Möbus, V.J., R. Kreienberg: Retrovirally mediated wildtype p53 restores S phase modulation without inducing WAF1 mRNA in breast carcinoma cells containing mutant p53. Jr. Cell. Biochem. Accepted (Feb 1995)

  2. Moëbus, V.J., Stein, R., Kieback, D.G., Runnebaum, I.G., Sass, G., Kreienberg, R. Antitumor activity of new organometallic compounds in human ovarian cancer cell lines and comparision to platin derivatives. Gynec. Oncol. Submitted, Nov. 1995.

  3. Kudelka, A.P., Levy, T., Kavanagh, J.J., Edwards, C.L., Gutterman, J.U., Mavligit, G., Kieback, D.G., Piamsomboon, S., Loyer, E., Verschraegen, C.F. Remission of cercical cancer with the novel angiogenesis inhibitor TNP-470: A brief report. Gynecol. Oncol. (submitted 4/96)

  4. Wiehle, R.D., Yangt, A., Sangi-Haghpeykar, H., Kieback, D.G., Wittliff, J.L. Relationship between steroid hormone receptors and the HER/2neu oncogene product in human breast cancer J. Clin Oncol. (Submitted 6/1996)

  5. Kudelka, A.P., Levy, T., Verschraegen, C.F., Edwards, C.L., Piamsomboon, S., Termrungruanglert, W., Kaplan, A.L., Kieback, D.G., Meyers, C.A., Jacckler, K.A., Loyer, E., Steger, M., Mante, R., Mavligit, G., Killian, A., Tang, R.A., Gutterman, J.U., Kavanagh, J.J. A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix. Clin Cancer Res (submitted 8/96)

  6. Tong, XW, Freund, CTF, Agoulnk I, Blankenburg K, Chen, S-H, Contant CF, Woo, SLC, Kieback DG: The efficacy of adenovirus-mediated gene therapy of ovarian cancer is enhanced by using the CMV promoter. (Submitted to BrJC)

  7. Tong, XW, Shine, DH, Agoulnik, I, Freund CTF, Blankenburg K, Hasenburg, A, Engehausen, DG, Kaplan, AL, Woo, SLC, Kieback, DG: Adenovirus mediated thymidine kjnase gene therapy may enhance sensitivity of ovarian cancer cells to slected chemotherapeutic agents. (Submitted to AmJOB)

ARTICLES IN PROGRESS

  1. Tong XW, Runnebaum IB, Kieback DG: The risk factors of ovarian cancer.
  2. Tong XW, Runnebaum IB, Kieback DG: The risk factors of breast cancer.
  3. Tong XW, Gu MJ, Agoulnik I, Blankenburg K, Atkinson EN, Runnebaum IB, Kieback DG: Race associated distribution of Progins is associated with high risk factor for developing ovarian cancer.
  4. Tong XW, Gu MJ, Agoulnik I, Blankenburg K, Atkinson EN, Runnebaum IB, Kieback DG: Race associated distribution of PIN-3 is associated with high risk factor for developing ovarian cancer
  5. Tong XW. Agoulnik I, Engehausen, DG, Blankenburg K, Kaufman RH, Contant CF, Woo SLC, Kieback DG: Improved treatment efficiacy of adenovirus-mediated gene therapy of ovarian cancer by using acyclovir.
  6. T Levy, I Agoulnik, E. N Atkinson, X-W Tong, H M. Gause, A Hasenburg, I B. Runnebaum, E Stickeler, V J. Möbus, A L. Kaplan, D G. Kieback: Telomere length in human peripheral white blood cells remains constant with age and is shorter in patients with breast cancer